KRAS and familial pancreatic carcinoma: KRAS mutation also downregulated hormone-sensitive lipase (HSL) by activating ERK signaling pathway to promote lipid storage and excess fatty acid storage in lipid droplets, which are required for pancreatic cancer cell proliferation and metastasis (Man et al., 2020).